Phase 1 clinical trials on a new gene therapy to treat age-related macular degeneration are currently underway in multiple locations around the country. Early results from the trials are offering promising results and researchers hope gene therapy for wet macular degeneration will be available within the next 3 to 5 years. This new therapy would […]
New Drug Approved for Wet Macular Degeneration
Novartis Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) has approved it’s new drug, Beovu®, for the treatment of wet age-related macular degeneration (AMD). Beovu® (brolucizumab) recently completed two late-stage clinical trials, which tested the safety and efficacy of the intravitreal injection. Wet AMD is an eye condition which can lead to a […]
October 14, 2019 By Leave a Comment
New implant delivers medicine continuously to eye
The current therapy for treating wet macular degeneration involves costly, frequent injections into the eye. Researchers are currently working on a new therapy that involves putting an implant into the eye that would continuously deliver the medication into the eye. Injection therapy only offers temporary help in preserving central vision with wet macular degeneration and […]
June 20, 2019 By Leave a Comment
Donor Cells Implanted for Macular Degeneration
Researchers at the Riken Institute in Japan completed the first clinical trial involving the transplantation of induced pluripotent stem cells (iPS cells) from donors. Five patients received the donated cells. Artificially grown retinal cells were made from donor iPS cells and were used to treat the patients suffering from wet age-related macular degeneration. The first […]
May 21, 2019 By Leave a Comment
Which medication is best for wet macular degeneration?
Johns Hopkins University School of Medicine researchers studied the ocular as well as systemic effects that three anti-VEGF therapies had on patients. Pegatanib, ranibizumab and bevacizumab were all compared to patients who received no anti-VEGF treatments Researchers evaluated specific studies from databases and focused on 16 randomized controlled trials that had a total of 6347 […]
March 30, 2019 By Leave a Comment
Revolutionary treatment restores vision
A study that involved a revolutionary treatment using stem cells from the eyes of non-living donors is detailed in STEM CELLS Translational Medicine. Researchers hope that this pioneering treatment may hold the key to finding a cure for blindness that is caused by damage to the cornea. Eight patients with condition known as Limbal stem […]
March 28, 2019 By Leave a Comment
Gene therapy used to treat AMD
A surgeon at the John Radcliffe Hospital in the UK successfully injected a synthetic gene into a patient’s eye in the hope of stopping the progression of age-related macular degeneration. The patient, Janet Osborne, is the first person to receive the gene therapy in the trial that is being conducted at the John Radcliffe Hospital […]
March 25, 2019 By Leave a Comment
Oranges reduce AMD risk 60%
Forget an apple a day to keep the doctor away, reach for an orange as a recent study shows that eating an orange a day can reduce your risk of developing late macular degeneration by as much as 60 percent. The flavonoids found in oranges provide a special protection against age-related macular degeneration. Researchers at […]
January 18, 2019 By Leave a Comment
Implantable Lucentis means fewer injections for wet macular degeneration
Fewer Injections for Wet Macular Degeneration? A tiny implantable device for the treatment of macular degeneration is in clinical trials and may be approved by the FDA. The device will lessen the burden of patients who currently must endure injections on a monthly basis to treat their wet form of macular degeneration. This breakthrough device […]
January 5, 2019 By Leave a Comment
No More Eye Injections for Wet Macular Degeneration?
Genetech has formulated Lucentis’ active ingredient into a refillable eye implant that delivers the medication continuously into the eyes of wet macular degeneration patients. Known as the Port Delivery System, the implantable drug has shown promising results in the second phase of clinical studies. The Port Delivery System is slightly bigger than a grain of […]
August 5, 2018 By Leave a Comment
Recent Comments